Clinical Trials Directory

Trials / Conditions / Thyroid Carcinoma

Thyroid Carcinoma

47 registered clinical trials studyying Thyroid Carcinoma13 currently recruiting.

StatusTrialSponsorPhase
RecruitingNanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
NCT07218315
M.D. Anderson Cancer CenterN/A
RecruitingLaryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
NCT07359586
Zhejiang University
RecruitingThyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
NCT07473518
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrolling By InvitationThe Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery
NCT06931743
Xiaonan HuangN/A
RecruitingAn International Study on Pediatric Patients With Rare Tumors.
NCT07072143
Azienda Ospedaliera di Padova
UnknownOPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults
NCT05949424
University Medical Center GroningenPhase 4
TerminatedStudy of IK-595 in RAS- or RAF-altered Advanced Tumors
NCT06270082
Ikena OncologyPhase 1
RecruitingPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924
Institut de Recherches Internationales ServierPhase 1 / Phase 2
RecruitingCEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma
NCT06146764
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
RecruitingRestor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
NCT05668962
Massachusetts General HospitalPhase 2
UnknownEuropean Multicenter Study on Surgical Management of Advanced Thyroid Cancer
NCT05796960
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RecruitingEvaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas
NCT06863805
IRCCS Azienda Ospedaliero-Universitaria di Bologna
CompletedImpact of the COVID-19 Pandemic on Surgery for Thyroid Cancer
NCT05178186
University of CagliariN/A
RecruitingEvaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
NCT06779747
IRCCS Azienda Ospedaliero-Universitaria di Bologna
CompletedOptimising Molecular Radionuclide Therapy
NCT04922801
King's College London
CompletedThyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW
NCT06095362
University Medical Center GroningenPhase 1
Active Not RecruitingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Express
NCT04802876
SOLTI Breast Cancer Research GroupPhase 2
RecruitingFunction Integrity of Neck Anatomy in Thyroid Surgery
NCT04666103
Wuhan UniversityN/A
TerminatedEffect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System
NCT04327999
Vanderbilt-Ingram Cancer CenterPhase 2
CompletedVemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
NCT04462471
Memorial Sloan Kettering Cancer CenterPhase 1
UnknownMalignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290
Umraniye Education and Research Hospital
RecruitingLesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
NCT03647358
Memorial Sloan Kettering Cancer CenterPhase 1
UnknownComparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection
NCT03500666
Fujian Medical UniversityN/A
UnknownCell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380
Christian von BuchwaldN/A
RecruitingInternational PPB/DICER1 Registry
NCT03382158
Children's Hospitals and Clinics of Minnesota
CompletedEvaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
NCT02658513
Royal Surrey County Hospital NHS Foundation Trust
CompletedStudy of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyr
NCT02614495
Hutchison Medipharma LimitedPhase 2
CompletedRenal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine
NCT02773667
Jena University Hospital
Active Not RecruitingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
Merck Sharp & Dohme LLCPhase 2
CompletedParathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparat
NCT02194920
University of Roma La Sapienza
CompletedMore Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if
NCT06439745
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active Not RecruitingProspective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unres
NCT02185560
Bayer
CompletedEnhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhib
NCT02145143
Memorial Sloan Kettering Cancer CenterEARLY_Phase 1
CompletedSorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
NCT02114658
BayerPhase 2
TerminatedA Study Into the Effect of Seprafilm in Open Total Thyroidectomy
NCT01865838
National Cancer Centre, SingaporeN/A
CompletedPhase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
NCT01813136
Centre Leon BerardPhase 2
WithdrawnThe Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT01707056
Medstar Health Research InstituteN/A
CompletedBiomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
NCT01433809
Norman Eberhardt
CompletedLipid Metabolic Status in Thyroid Carcinoma
NCT01487057
Prof. Dr. I. Chiricuta Institute of Oncology
CompletedEfficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain
NCT01126060
Samsung Medical CenterPhase 3
CompletedTrial of LBH589 in Metastatic Thyroid Cancer
NCT01013597
University of Wisconsin, MadisonPhase 2
UnknownFeasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
NCT00993837
Second Military Medical UniversityN/A
UnknownInfluence of Thyroid Hormones on the Woundhealing Process
NCT00929318
Hannover Medical SchoolN/A
UnknownRadioiodine Dosimetry Protocol for Thyroid Cancer Metastases
NCT00749697
Royal Marsden NHS Foundation TrustN/A
TerminatedClinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
NCT00647140
Assistance Publique - Hôpitaux de ParisPhase 2
CompletedThyroid Cancer and Sunitinib
NCT00510640
University Hospital, BordeauxPhase 2
CompletedStudy of XL184 (Cabozantinib) in Adults With Advanced Malignancies
NCT00215605
ExelixisPhase 1